Secondary attack rate of mumps?
What is the significance of the 1st of July in demographic studies?
What is the definition of an endemic disease?
A screening test has sensitivity of 90% and specificity of 99%. The prevalence of disease under investigation is 5 per 1000 population. What is the PPV of the given screening test?
What does the secondary attack rate measure?
Sensitivity of a screening test tells about
Best indicator for spread of TB in a community?
During investigation of an epidemic, the area is declared free of epidemic when?
Which of the following correctly describes the components of the epidemiological triad?
Strength of association of outcome and risk factor is measured by?
Explanation: ***75%*** - The **secondary attack rate** for mumps is approximately **75%**, indicating its high transmissibility among susceptible household contacts. - This high rate underscores the importance of vaccination to prevent spread in close-contact settings. *85%* - While mumps is highly contagious, an 85% secondary attack rate is generally considered too high and not reflective of typical epidemiological data. - This percentage is more commonly associated with diseases like measles, which has an even higher transmissibility. *95%* - A 95% secondary attack rate is characteristic of highly contagious diseases like **measles**, which transmit very efficiently even in short, casual contacts. - Mumps, while highly infectious, does not typically reach this level of secondary attack rate. *< 50%* - A secondary attack rate of less than 50% would suggest lower transmissibility than what is observed for mumps. - Diseases with lower secondary attack rates are generally less prone to rapid outbreaks among close contacts.
Explanation: ***1st July*** - The **1st of July** is often considered the **mid-year population estimate** in demographic studies. - This date is crucial for calculating rates (e.g., birth rates, death rates) and making projections, as it provides a standardized reference point that balances out seasonal population fluctuations. *1st January* - While a significant date for many annual administrative purposes, the **1st of January** represents the beginning of the year, not the mid-point. - Using this date for population counts can sometimes overemphasize the population at the start of a new calendar cycle, potentially skewing annual rate calculations. *1st September* - The **1st of September** falls in the third quarter of the year and does not represent a standard mid-year point for demographic estimations. - This date has no widely recognized statistical significance for population estimation in demographic contexts. *15th June* - The **15th of June** is close to the middle of the year but is not the conventionally adopted date for mid-year population estimates. - Demographers prefer standard, easily replicable dates for consistency across regions and studies.
Explanation: ***Disease occurring regularly in expected frequency*** - An **endemic disease** is consistently present in a population within a given geographic area at an **expected frequency**. - This implies that the disease is **always circulating** and has a baseline level of incidence. *Disease occurring in excess of expected frequency* - This definition describes an **epidemic**, where the disease occurrence is significantly higher than what is normally expected for that population. - While an endemic disease can become an epidemic, the core definition of endemic does not include an excess frequency. *Disease affecting a large population* - Affecting a large population is not the defining characteristic of an endemic disease; rather, it refers to the **scale** or **reach** of a disease. - A disease can affect a large population without being endemic, such as a widespread pandemic that is not regularly present in every affected region. *Disease occurring irregularly* - Irregular occurrence describes a more **sporadic** pattern of disease, where cases appear inconsistently and without a predictable frequency. - An **endemic disease** is characterized by its regular and predictable presence, even if the number of cases fluctuates within expected limits.
Explanation: ***33*** * **Positive Predictive Value (PPV)** = \[Sensitivity \times Prevalence] / \[(Sensitivity \times Prevalence) + (1 – Specificity) \times (1 – Prevalence)] * Here, 0.9 x 0.005 / \[(0.9 x 0.005) + (1-0.99) x (1-0.005)] = 0.0045 / \[0.0045 + (0.01 x 0.995)] = 0.0045 / \[0.0045 + 0.00995] = 0.0045 / 0.01445 ≈ 0.3114 or 31.14%. Converting to a percentage closest to the answer choices, it would be 33%. *10* * This value would be obtained if there was an error in calculating either the **prevalence** of the disease or the contribution of false positives to the total positive tests. * Inaccuracies in the formula or arithmetic would lead to results far from the correct PPV. *70* * This value suggests a much higher **prevalence** or a significantly lower number of **false positives** than indicated by the given sensitivity, specificity, and prevalence. * Such a high PPV is inconsistent with a low disease prevalence (0.5%) and a relatively high false positive rate (1-specificity = 1%). *99* * This value is close to the given **specificity**, which is the probability of a true negative test among individuals without the disease, not the PPV. * A PPV of 99% would be extremely high for a disease with a prevalence of 0.5% and would typically require a much higher specificity and/or sensitivity.
Explanation: ***The proportion of susceptible people who become infected after exposure to a primary case*** - This is the **correct definition** of the **secondary attack rate (SAR)** - SAR = (Number of new cases among contacts of primary cases) / (Total number of susceptible contacts at risk) - It is typically measured within one incubation period after exposure - Commonly used to assess transmission in **households or closed populations** (schools, institutions, etc.) - Important measure of **communicability** of infectious diseases in real-world settings *The ability of a disease to spread from one person to another* - This broadly describes **transmissibility** or **infectivity** but is too general - The **basic reproductive number (R₀)** is the specific measure of disease spread in a fully susceptible population - SAR is more specific, measuring spread among actual contacts *The ability of a disease to cause death* - This describes **case fatality rate (CFR)** or **virulence** - CFR = (Number of deaths from disease) / (Total number of cases) × 100 - Completely different concept from secondary attack rate *The rate at which a disease progresses in severity* - This describes **disease progression** or **natural history** of disease - Not related to the secondary attack rate concept - SAR measures **spread between people**, not progression within an individual
Explanation: ***Percentage of individuals with the disease who test positive*** - **Sensitivity** measures the ability of a test to correctly identify individuals who *have* the **disease**. - It's calculated as (True Positives / (True Positives + False Negatives)) * 100, representing the **true positive rate**. *Percentage of healthy individuals among those with a negative test result* - This describes the **negative predictive value (NPV)**, which is the probability that a person who tests negative truly does not have the disease. - NPV is crucial for ruling out disease in a population. *Percentage of individuals with the disease among those with a positive test result* - This is the definition of **positive predictive value (PPV)**, indicating the probability that a person who tests positive truly has the disease. - PPV is important for confirming a diagnosis in clinical practice. *Percentage of healthy individuals among those with a positive test result* - This describes 1 minus the positive predictive value, or the rate of **false positives** among those who test positive. - A high rate here means many healthy individuals are incorrectly identified as having the disease.
Explanation: ***Annual infection rate*** - The **Annual Infection Rate (ARI)** is the gold standard indicator for measuring TB spread in a community - It measures the rate at which new TB infections occur in a tuberculin-negative population over one year - ARI directly reflects **recent transmission** and the force of infection in the community - WHO and Park's Textbook recommend ARI as the best epidemiological indicator for TB transmission - Calculated through tuberculin surveys showing conversion from negative to positive - An ARI of 1% indicates 1% of uninfected individuals become infected per year *Incidence of new cases* - Incidence measures new **disease cases** (active TB), not new infections - Only 5-10% of TB infections progress to active disease, often after years of latency - Incidence is affected by case detection rates, diagnostic capacity, and healthcare access - It underestimates actual transmission occurring in the community *Prevalence of infection* - **Prevalence** indicates total existing cases (both old and new) at a point in time - Influenced by both new infections and duration of infection/disease - Does not specifically measure the rate of ongoing transmission *Case rate* - **Case rate** refers to the number of active disease cases per population - Similar to prevalence, it doesn't isolate new transmission events - Less sensitive for detecting changes in transmission dynamics
Explanation: ***Twice the incubation period of the disease since occurrence of the last case*** - An epidemic is declared over when there have been no new cases for a period equal to **twice the maximum incubation period** of the disease. - This timeframe ensures that any individuals who might have been infected by the last known case would have developed symptoms (or completed their infectivity period) within this observation window. *Thrice the incubation period of the disease since occurrence of the last case* - This duration is **excessively long** and not the standard public health measure for declaring an epidemic free. - While it provides an even greater margin of safety, it is not the most **efficient or practical threshold** for public health interventions. *The longest incubation period for the disease* - Observing for only the **longest incubation period** is insufficient because a new case could still emerge at the very end of this period, potentially starting a new chain of transmission. - It does not account for the possibility of **secondary cases** occurring at the extreme end of the incubation period. *Incubation period for the disease plus two standard deviations* - This statistical measure is typically used to define the **range of normal variation** for biological data, not for epidemic declaration. - While it relates to the incubation period, it is **not the established public health standard** for determining the end of an epidemic.
Explanation: **Agent, host, environment** * The **epidemiological triad** is a classic model that describes the interrelationships contributing to disease development. * It consists of the **agent** (the causative factor), the **host** (the organism contracting the disease), and the **environment** (extrinsic factors influencing exposure and susceptibility). * *Time, place, person (descriptive epidemiology)* * **Time, place, and person** are key components of **descriptive epidemiology**, used to characterize disease patterns. * While important for understanding disease distribution, they do not represent the causative interconnectedness of the epidemiological triad. * *Disease, prevention, treatment (healthcare process)* * **Disease, prevention, and treatment** describe aspects of the healthcare process and public health interventions. * They are not the fundamental components used to explain the *occurrence* of disease as modeled by the epidemiological triad. * *Agent, disease, vector (lacks host and environmental components)* * This option includes the **agent** and a **vector** (which is a type of environmental factor or can be considered part of the agent's transmission). * However, it misses the crucial component of the **host** and fully encompassing the broader **environment**.
Explanation: ***Relative risk*** - **Relative risk (RR)** directly measures the **strength of association** between exposure to a risk factor and the development of an outcome. - It is calculated as the ratio of the **incidence rate** in the exposed group to the incidence rate in the unexposed group. *Attributable risk* - **Attributable risk (AR)** measures the **absolute difference** in outcome rates between exposed and unexposed groups, indicating the extra cases due to exposure. - It quantifies the **public health impact** or burden of disease that can be attributed to the exposure, rather than the strength of association. *Population attributable risk* - **Population attributable risk (PAR)** estimates the proportion of disease incidence in the **total population** that is attributable to an exposure. - It considers both the **strength of the association** and the **prevalence of the exposure** in the population, making it more about public health impact than individual strength of association. *None of the options* - This option is incorrect because **relative risk** is a fundamental epidemiological measure for determining the strength of association.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free